Page last updated: 2024-10-30

leflunomide and Leishmaniasis, American

leflunomide has been researched along with Leishmaniasis, American in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"Leflunomide has been reported as an immunomodulating agent which acts on a variety of cells including T- and B-lymphocytes."1.29Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice. ( Asmuss, PA; Humborg, C; Röllinghoff, M; Solbach, W; Zimmermann, S, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Solbach, W1
Asmuss, PA1
Zimmermann, S1
Humborg, C1
Röllinghoff, M1

Other Studies

1 other study available for leflunomide and Leishmaniasis, American

ArticleYear
Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice.
    International journal of immunopharmacology, 1995, Volume: 17, Issue:6

    Topics: Animals; Antiparasitic Agents; Antiprotozoal Agents; Female; Genetic Predisposition to Disease; Immu

1995